FeesSafety
Pluang+

Taboola reports Q3 2026 revenue of $462M with 16% rise in adjusted EBITDA, expects growth in Q4 and full year.

Company Fundamentals
04 Nov 2026, 13:15 WIB
GlobeNewsWire
View Source
Bullish
Taboola reports Q3 2026 revenue of $462M with 16% rise in adjusted EBITDA, expects growth in Q4 and full year.

Taboola announced its Q3 2026 financial results with revenues of $462.3 million, a 6.9% decline from last year, but adjusted EBITDA rose 16.1% to $56 million, reflecting improved profitability. The company focuses on expanding its publisher base, increasing revenue from existing partners, and investing in growth areas like Taboola News and social commerce. For Q4 2026, Taboola projects revenues between $477 million and $493 million and adjusted EBITDA between $73.5 million and $82.5 million, signaling confidence in continued growth despite recent revenue decline. The company also expects to close its Dianomi acquisition by year-end, enhancing its market position.

Taboola's Q3 2026 financial results provide context for readers interested in digital media companies. For readers following the Media sector, here is Pluang's market snapshot as of Nov 04, 2026 18:02 WIB: out of 57 priced US Media stocks, 37 rose and 17 fell. Notable movers include TLK at USD 10.60 with a 1-day change of +1.92%, ECHO at USD 100.16 down 1.75%, and FVRR at USD 8.39 up 1.70%.

More News

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...

Market News
Bullish
32 minutes ago
Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...

Market News
Neutral
1 hour ago
etoro acquires Argentine fintech LB Finanzas to expand in Latin America

etoro acquires Argentine fintech LB Finanzas to expand in Latin America

etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...

Company Fundamentals
Bullish
1 hour ago
JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...

Company Fundamentals
Neutral
4 hours ago
KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App